State Street’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
State Street's ADPT Position: Q2 2026 in Review
State Street increased its Adaptive Biotechnologies (ADPT) stake by 7.2% in Q2 2026, buying an estimated $3.54M and bringing the position to 3,458,388 shares worth $74.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1647.
State Street first reported a position in ADPT in Q3 2019 and has held it in 28 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- State Street held 3,458,388 shares of Adaptive Biotechnologies worth $74.2M as of Q2 2026.
- State Street bought 231,143 Adaptive Biotechnologies shares in Q2 2026, an estimated $3.54M.
- Adaptive Biotechnologies made up ﹤0.01% of State Street's portfolio in Q2 2026, its #1647 holding.
- State Street first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 28 quarters since.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.